Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

ClinicalTrials.gov ID: NCT03478982

Public ClinicalTrials.gov record NCT03478982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, double-blind, randomized, parallel group, dose-ranging study to investigate the efficacy and clinical usability of STAP-001 in adult (18 years of age and older) subjects with epilepsy with a predictable seizure pattern. These subjects have an established diagnosis of focal or generalized epilepsy with a documented history of predictable seizure episodes. This is an in-patient study. The subjects will be admitted to a Clinical Research Unit (CRU) or Epilepsy Monitoring Unit (EMU) for study participation. The duration of the stay in the in-patient unit will be 2-8 days. One seizure event per subject will be treated with study medication. The duration and timing of the seizure event and occurrence of subsequent seizures will be assessed by the Staff Caregiver(s)1 through clinical observation and confirmed with video electroencephalogram (EEG).

Study identification

NCT ID
NCT03478982
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Engage Therapeutics, Inc.
Industry
Enrollment
156 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2018 (Actual)
Primary completion
Dec 22, 2019 (Actual)
Completion
Jan 4, 2020 (Actual)
Last update posted
Feb 3, 2021

2018 – 2020

United States locations

U.S. sites
63
U.S. states
29
U.S. cities
51
Facility City State ZIP Site status
UAB Hospital Birmingham Alabama 35294 —
University of Arizona Phoenix Arizona 85006 —
St. Joseph's Hospital and Medical Center - Barrow Neurological Institute Phoenix Arizona 85013 —
Clinical Trials Inc Little Rock Arkansas 72205 —
Rancho Research Institute Inc. Downey California 90242 —
UCLA Los Angeles California 90095 —
Hoag Hospital Newport Beach California 92663 —
Stanford Neuroscience Health Center Palo Alto California 94304 —
Havana Research Institute LLC. Pasadena California 91105 —
University of Colorado Aurora Colorado 80045 —
Yale University New Haven Connecticut 06511 —
VA Connecticut Healthcare System West Haven Connecticut 06516 —
Georgetown University Hospital Washington D.C. District of Columbia 20007 —
GW Medical Faculty Associates Washington D.C. District of Columbia 20037 —
NW FL Clinical Research Group LLC Gulf Breeze Florida 32561 —
University of Florida Health Science Center Jacksonville Jacksonville Florida 32209 —
Mayo Clinic Florida Jacksonville Florida 32224 —
Clinical Translational Research Site Miami Florida 33136 —
Advanced Pharma Cr, LLC Miami Florida 33147 —
Nicklaus Children's Hospital Miami Florida 33155 —
AdventHealth Orlando Orlando Florida 32803 —
Research Institute of Orlando, LLC Orlando Florida 32806 —
NeuroMedical Research Institute Panama City Florida 33607 —
Center for Rare Neurological Diseases Norcross Georgia 30093 —
Clinical Research Institute Stockbridge Georgia 30281 —
Hawaii Pacific Neuroscience Honolulu Hawaii 96817 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Ochsner Health System New Orleans Louisiana 70121 —
Maine Medical Center Scarborough Maine 04074 —
Mid-Atlantic Epilepsy And Sleep Center, LLC Bethesda Maryland 20817 —
Harvard Medical School - Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48109 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
SRI International West Bloomfield Michigan 48322 —
Washington University School of Medicine St Louis Missouri 63110 —
Impact Clinical Trials Las Vegas Las Vegas Nevada 89106 —
JFK Medical Center Edison New Jersey 08820 —
Institute of Neurology & Neurosurgery at St. Barnabas Livingston New Jersey 07039 —
Rutgers University New Brunswick New Jersey 08901 —
Dent Neurologic Institute Amherst New York 14226 —
SUNY Downstate Medical Center - Comprehensive Epilepsy Center Brooklyn New York 11203 —
Kaleida Health Oishei Children's Hospital Buffalo New York 14203 —
NYU Comprehensive Epilepsy Center New York New York 10016 —
Mount Sinai Health System New York New York 10029 —
Lenox Hill Hospital New York New York 10075 —
University of Rochester Medical Center Rochester New York 14642 —
Carolinas Neurosciences Institute Charlotte North Carolina 28207 —
OnSite Clinical Solutions, LLC Concord North Carolina 28025 —
The Promedica-University of Toledo Neuroscience Center Toledo Ohio 43606 —
Oregon Health & Science University - Brain Institute - Comprehensive Epilepsy Center Portland Oregon 97239 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Lewis Katz School of Medicine at Template University Philadelphia Pennsylvania 19140 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
University of Texas Southwestern Medical Center - Neurology Clinic Dallas Texas 75390 —
UT Houston Houston Texas 77030 —
Clinical Trial Network Houston Texas 77074 —
University of Utah Hospital Salt Lake City Utah 84132 —
Centra Medical Group Neurology Center Lynchburg Virginia 24502 —
Carilion Roanoke Memorial Hospital Roanoke Virginia 24014 —
Multi-Care Institute for Research and Innovation Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03478982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03478982 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →